Physician profile
Allan Pickens
NPI 1437165610
$86,567.11
in general payments reported to CMS, 2019-2025
22 companies · $5,906 in 2025
The $5,906 reported for 2025 was more than what 84% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $23K · 2021: $16K · 2022: $8,026 · 2023: $2,681 · 2024: $4,997 · 2025: $5,906.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,795 · Education: $4,233 · Travel and Lodging: $2,526 · Consulting Fee: $1,515 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,794.94 |
| Education | $4,233.24 |
| Travel and Lodging | $2,525.62 |
| Consulting Fee | $1,515.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $39,912.16 | 2019-2023 | Echelon Endopath, Harmonic, Echelon Flex |
| Intuitive Surgical, INC. | $35,652.01 | 2019-2025 | Da Vinci Surgical System |
| Ethicon US, LLC | $6,256.80 | 2019-2025 | Echelon Flex |
| Medtronic, INC. | $1,256.95 | 2022-2025 | Signia, Illumisite, Ligasure |
| Merck Sharp & Dohme LLC | $1,097.25 | 2021 | |
| Atricure, INC. | $592.59 | 2023-2025 | Atricure Cryoice Cryosphere Cryoablation System, Atricure Cryoice Cryosphere Cryoablation System |
| Ethicon INC. | $561.57 | 2019-2022 | |
| On Target Laboratories, INC | $205.59 | 2024-2025 | Cytalux |
| Artivion, INC. | $188.92 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $161.44 | 2025 | Tagrisso |
| Janssen Biotech, INC. | $141.08 | 2025 | Rybrevant |
| Karl Storz Endoscopy-America | $135.61 | 2020-2023 | |
| Abbott Laboratories | $119.85 | 2023-2024 | Epic |
| Stryker Corporation | $66.80 | 2024 | Actishield Cf |
| Conmed Corporation | $45.39 | 2025 | Airseal, Conmed Specimen Retrieval |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $43.48 | 2025 | Zipfix |
| Edwards Lifesciences Corporation | $39.37 | 2022 | |
| Davol INC. | $28.26 | 2025 | Progel Applicator Spray Tips |
| Tela Bio, INC. | $25.17 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Novartis Pharmaceuticals Corporation | $19.30 | 2025 | |
| Kls-Martin L.P. | $17.52 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allan Pickens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.